A detailed history of Verdad Advisers, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Verdad Advisers, LP holds 11,988 shares of MRK stock, worth $1.19 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
11,988
Previous 11,988 -0.0%
Holding current value
$1.19 Million
Previous $1.48 Million 8.29%
% of portfolio
1.81%
Previous 1.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$123.8 - $132.96 $27,731 - $29,783
-224 Reduced 1.83%
11,988 $1.48 Million
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $1.38 Million - $1.61 Million
12,212 New
12,212 $1.61 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Verdad Advisers, LP Portfolio

Follow Verdad Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Verdad Advisers, LP with notifications on news.